Scrutinizer Report for the Postal Ballot of the Company ended on 28th May, 2026
Awaiting price reaction for this filing.
Avi Products India Ltd has completed a postal ballot with voting ending 28th May 2026, declaring results on 30th May 2026. All 13 resolutions (11 Special and 2 Ordinary) were passed with requisite majority. The most significant change is a complete overhaul of the company's object clause in the Memorandum of Association, adding real estate development, healthcare services including dental clinics and hospitals, diagnostic centers, food processing, IT services, and many other businesses - signaling a major business diversification from their original chemical/photographic operations. The company is also shifting its registered office from Vasai (Thane) to Khar West, Mumbai. Five additional directors appointed in April 2026 have been regularized, including Mr. Parthh K Mehta as Executive Director and Chairman, Mr. Ameya Tandulkar as Executive Director, Mr. Bankim Mehta as Non-Executive Director, Ms. Malvika Jagani as Independent Woman Director, Mr. Dayashankar Patel and Mr. Aditya Soni as Independent Directors. The company also secured approvals to increase borrowing limits, create charges on assets, and authorize loans/investments under Sections 180, 185, and 186 of the Companies Act, 2013, along with material related party transaction approvals.
This represents a fundamental transformation of the company from a niche chemical/photographic products business into a diversified conglomerate with real estate, healthcare, and food processing operations. The shift to Mumbai and expanded borrowing powers suggest ambitious growth plans, but also increased financial risk. Shareholders should note the potential dilution of focus from core business and increased related party transaction exposure.